BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26317270)

  • 1. Viewing Lung Cancer in Color Instead of Black and White.
    Detterbeck FC
    Ann Am Thorac Soc; 2015 Aug; 12(8):1118-9. PubMed ID: 26317270
    [No Abstract]   [Full Text] [Related]  

  • 2. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
    Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
    Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overdiagnosis Detrimental, Resection Consequential, NLST Challengeable.
    Reich JM; Kim JS
    Acad Radiol; 2016 Jan; 23(1):112-3. PubMed ID: 26601896
    [No Abstract]   [Full Text] [Related]  

  • 4. Coexistent pulmonary inflammatory pseudotumor and carcinoma in one patient: does positron emission tomography/computed tomography help.
    Zheng Z; Pan Y; Pan T; Li J
    Ann Thorac Surg; 2011 Mar; 91(3):e43. PubMed ID: 21352969
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung cancer: positron emission tomography/computed tomography and the new staging system.
    Rakheja R; Ko JP; Friedman K
    Semin Roentgenol; 2013 Oct; 48(4):308-22. PubMed ID: 24034263
    [No Abstract]   [Full Text] [Related]  

  • 6. Overdiagnosis in Lung Cancer Screening can be Reduced to a Low, Manageable Level via a Multilayered Strategy Involving Perfecting Reporting Systems, Restricting Screening to High-Risk Groups, Developing Better Risk Stratification Models, and Improving Management Algorithms.
    Mortani Barbosa EJ
    Acad Radiol; 2016 Jan; 23(1):113-5. PubMed ID: 26514433
    [No Abstract]   [Full Text] [Related]  

  • 7. IASLC Lung Cancer Staging Project--a radiologist perspective.
    Raj JV; Coulden R; Entwisle J
    J Thorac Oncol; 2008 Mar; 3(3):318-9; author reply 319-20. PubMed ID: 18317079
    [No Abstract]   [Full Text] [Related]  

  • 8. [X-ray and emission-computed tomography in the diagnosis of lung cancer].
    Arsen'ev AI; Beĭnusov DS; Barchuk AS; Novikov SN; Kanaev SV; Barchuk AA; Gagua KÉ; Tarkov SA; Nefedov AO; Mamontov OIu; Shuginova TN
    Vopr Onkol; 2013; 59(1):18-24. PubMed ID: 23805446
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated vertebral metastasis with a fluid-fluid level from a poorly differentiated adenocarcinoma.
    Jarraya M; Hayashi D; Lebreton C; Côté JF; Guermazi A; Vallée C
    Diagn Interv Radiol; 2013; 19(3):233-6. PubMed ID: 23233407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer.
    Akhurst T; MacManus M; Hicks RJ
    PET Clin; 2015 Apr; 10(2):147-58. PubMed ID: 25829084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endobronchial ultrasound-guided transbronchial needle aspiration for staging patients with lung cancer with clinical N0 disease.
    Czarnecka K; Yasufuku K
    Ann Am Thorac Soc; 2015 Mar; 12(3):297-9. PubMed ID: 25786148
    [No Abstract]   [Full Text] [Related]  

  • 12. A rare non-small cell lung cancer (18)F-FDG PET/CT study in a young patient with genetic anomaly living in a highly polluted area. Metastatic lesions not shown by CT.
    Antoniou D; Vlachou F; Filippi V; Efthimiadou R; Prassopoulos V
    Hell J Nucl Med; 2013; 16(2):144-5. PubMed ID: 23687645
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity of diffusion weighted imaging for the assessment of metastatic lymph nodes.
    Meng J; Zhang G; Liang W; Xu S
    Eur J Radiol; 2011 Nov; 80(2):620. PubMed ID: 21459530
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers.
    Healy MA; Yin H; Reddy RM; Wong SL
    J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26903519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-2-Deoxy-d-Glucose positron emission tomography-computed tomography in lung cancer.
    Delappe E; Dunphy M
    Semin Roentgenol; 2011 Jul; 46(3):208-23. PubMed ID: 21726705
    [No Abstract]   [Full Text] [Related]  

  • 16. Low dose CT screening for lung cancer.
    Baldwin DR; Ten Haaf K; Rawlinson J; Callister MEJ
    BMJ; 2017 Dec; 359():j5742. PubMed ID: 29284594
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.
    Pastorino U; Landoni C; Marchianò A; Calabrò E; Sozzi G; Miceli R; Picchio M; Mariani L; Messa C; Fazio F
    J Thorac Oncol; 2009 Nov; 4(11):1352-6. PubMed ID: 19861905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
    Okada M; Nakayama H; Okumura S; Daisaki H; Adachi S; Yoshimura M; Miyata Y
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT and PET appearance of a pigmented "black" adrenal adenoma in a patient with lung cancer.
    Prince EA; Yoo DC; DeLellis RA; Mayo-Smith WW
    Clin Radiol; 2007 Dec; 62(12):1229-31. PubMed ID: 17981173
    [No Abstract]   [Full Text] [Related]  

  • 20. ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
    Murakami S; Saito H; Karino F; Kondo T; Oshita F; Ito H; Nakayama H; Yokose T; Yamada K
    Eur J Radiol; 2013 Nov; 82(11):e721-5. PubMed ID: 23988690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.